Abstract
Both murine CD4+ and CD8+ cells are found in the thyroid infiltrate in experimental autoimmune thyroiditis (EAT) induced with mouse thyroglobulin (MTg). MTg activation of immune cells in vitro enables CD4+ cells to transfer thyroiditis adoptively and to aid the cytotoxic capacity of CD8+ cells for thyroid monolayers. To dissect their relative contribution to pathogenesis in vivo, depleting doses of paired rat monoclonal antibodies (MoAb) recognizing two distinct CD4 or CD8 epitopes were injected alone or in combination. Early treatment with CD4 MoAb interfered with the induction and development of EAT, whereas similar treatment with CD8 MoAb reduced infiltration moderately and did not enhance antibody response. To examine the long-term effect of therapy on advancing EAT, administration of MoAb was delayed to days 21 and 25, and thyroids were analysed immunohistochemically on days 28 and 70. Whereas control mice showed about 30% CD4+ and CD8+ cells at a 2:1 ratio (the remainder being mostly macrophages) on both days 28 and 70, the CD4 therapy regime led to reduced severity and the lesions on day 70 contained very low percentage of CD4+ cells, but elevated percentage of CD8+ cells (ratio 1:3.5). The CD8 therapy regime led to reduced CD8+ cells without changing the range of CD4+ cells (ratio 4:1). Thus, subset involvement may be influenced by the MoAb used. When CD4 and CD8 MoAb were combined, greater than 50% of the thyroids were cleared of all inflammatory cells; lesions when found were very small and contained less than 10% T cells (ratio 1:1). Since emerging T cells were not retained in the thyroid despite ongoing antigenic stimulus leading to increased antibody titres, the therapeutic effect of MoAb, even at an advanced stage of disease, was long lasting.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aqel N. M., Clark M., Cobbold S. P., Waldmann H. Immunohistological screening in the selection of monoclonal antibodies: the use of isotype-specific antiglobulins. J Immunol Methods. 1984 Apr 27;69(2):207–214. doi: 10.1016/0022-1759(84)90319-3. [DOI] [PubMed] [Google Scholar]
- Bagnasco M., Ferrini S., Venuti D., Prigione I., Torre G., Biassoni R., Canonica G. W. Clonal analysis of T lymphocytes infiltrating the thyroid gland in Hashimoto's thyroiditis. Int Arch Allergy Appl Immunol. 1987;82(2):141–146. doi: 10.1159/000234179. [DOI] [PubMed] [Google Scholar]
- Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature. 1984 Dec 6;312(5994):548–551. doi: 10.1038/312548a0. [DOI] [PubMed] [Google Scholar]
- Cobbold S. P., Martin G., Qin S., Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature. 1986 Sep 11;323(6084):164–166. doi: 10.1038/323164a0. [DOI] [PubMed] [Google Scholar]
- Cobbold S., Waldmann H. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets. Transplantation. 1986 May;41(5):634–639. doi: 10.1097/00007890-198605000-00016. [DOI] [PubMed] [Google Scholar]
- Creemers P., Giraldo A. A., Rose N. R., Kong Y. M. T-cell subsets in the thyroids of mice developing autoimmune thyroiditis. Cell Immunol. 1984 Sep;87(2):692–697. doi: 10.1016/0008-8749(84)90037-6. [DOI] [PubMed] [Google Scholar]
- Creemers P., Rose N. R., Kong Y. M. Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J Exp Med. 1983 Feb 1;157(2):559–571. doi: 10.1084/jem.157.2.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ElRehewy M., Kong Y. M., Giraldo A. A., Rose N. R. Syngeneic thyroglobulin is immunogenic in good responder mice. Eur J Immunol. 1981 Feb;11(2):146–151. doi: 10.1002/eji.1830110216. [DOI] [PubMed] [Google Scholar]
- Esquivel P. S., Rose N. R., Kong Y. C. Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med. 1977 May 1;145(5):1250–1263. doi: 10.1084/jem.145.5.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
- Kantwerk G., Cobbold S., Waldmann H., Kolb H. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice. Clin Exp Immunol. 1987 Dec;70(3):585–592. [PMC free article] [PubMed] [Google Scholar]
- Kong Y. M., Giraldo A. A., Waldmann H., Cobbold S. P., Fuller B. E. Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression. Clin Immunol Immunopathol. 1989 Apr;51(1):38–54. doi: 10.1016/0090-1229(89)90204-3. [DOI] [PubMed] [Google Scholar]
- Kong Y., David C. S., Giraldo A. A., Elrehewy M., Rose N. R. Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J Immunol. 1979 Jul;123(1):15–18. [PubMed] [Google Scholar]
- Mackenzie W. A., Davies T. F. An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunology. 1987 May;61(1):101–103. [PMC free article] [PubMed] [Google Scholar]
- Nash A. A., Jayasuriya A., Phelan J., Cobbold S. P., Waldmann H., Prospero T. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol. 1987 Mar;68(Pt 3):825–833. doi: 10.1099/0022-1317-68-3-825. [DOI] [PubMed] [Google Scholar]
- Qin S., Cobbold S., Tighe H., Benjamin R., Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol. 1987 Aug;17(8):1159–1165. doi: 10.1002/eji.1830170813. [DOI] [PubMed] [Google Scholar]
- Rose N. R., Twarog F. J., Crowle A. J. Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol. 1971 Mar;106(3):698–704. [PubMed] [Google Scholar]
- Shizuru J. A., Taylor-Edwards C., Banks B. A., Gregory A. K., Fathman C. G. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science. 1988 Apr 29;240(4852):659–662. doi: 10.1126/science.2966437. [DOI] [PubMed] [Google Scholar]
- Stein H., Gatter K., Asbahr H., Mason D. Y. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest. 1985 Jun;52(6):676–683. [PubMed] [Google Scholar]
- Stull S. J., Kyriakos M., Sharp G. C., Braley-Mullen H. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development. Cell Immunol. 1988 Nov;117(1):188–198. doi: 10.1016/0008-8749(88)90087-1. [DOI] [PubMed] [Google Scholar]
- Sugihara S., Izumi Y., Yoshioka T., Yagi H., Tsujimura T., Tarutani O., Kohno Y., Murakami S., Hamaoka T., Fujiwara H. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis. J Immunol. 1988 Jul 1;141(1):105–113. [PubMed] [Google Scholar]
- Waldor M. K., Sriram S., Hardy R., Herzenberg L. A., Herzenberg L. A., Lanier L., Lim M., Steinman L. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science. 1985 Jan 25;227(4685):415–417. doi: 10.1126/science.3155574. [DOI] [PubMed] [Google Scholar]
- Watt S. M., Gilmore D. J., Davis J. M., Clark M. R., Waldmann H. Cell-surface markers on haemopoietic precursors. Reagents for the isolation and analysis of progenitor cell subpopulations. Mol Cell Probes. 1987 Dec;1(4):297–326. doi: 10.1016/0890-8508(87)90013-2. [DOI] [PubMed] [Google Scholar]